Lyora Therapeutics, Inc.
Form D Filings
Location
Belmont, MA
Industry Group
Biotechnology
Related People
Luc Vandenberghe, PhD
,
Eric Pierce, MD, PhD
Entity Type
Corporation
CIK
0002058969
All SEC Filings
View on sec.gov
Date Filed
Security Types
Total Amount Sold
Total Offering
Amount Remaining
First Sale
Signed
Form
SEC Link
3/11/2025
Option to Acquire
$525,000
$2,000,000
$1,475,000
2/25/2025
3/8/2025
D
000205896925000001